Blood Collection From Individuals With Lung Disease for Genetic Studies
NCT ID: NCT00362739
Last Updated: 2016-04-29
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
3087 participants
OBSERVATIONAL
2005-09-30
2015-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Blood Collection From Individuals With Lung Disease for Genetic Studies (Qatar)
NCT00504361
Collection of Blood for Gene Expression Study in Individuals With Chronic Lung Diseases
NCT00320151
Role of Genetic Factors in the Development of Lung Disease
NCT00001532
Collection of Airway, Blood and/or Urine Specimens From Subjects for Research Studies
NCT01776398
Examining the Genetic Factors That May Cause Chronic Obstructive Pulmonary Disease (COPD)
NCT00608764
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
1: Lung Disease
Individuals with at least one of the following: (1)symptoms consistent with pulmonary disease; (2) chest X-ray consistent with lung disease; (3) pulmonary function tests consistent with lung disease; (4) lung biopsy consistent with lung disease; (5) family history of lung disease; (6) patients with diseases of organs with known association with lung disease; (7) individuals suspected of history of lung diseased based on history and/or physical examination
No interventions assigned to this group
2: Normal Controls
Individuals without a history of lung disease
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Males and females, age 18 years and older
* Lung disease proven by at least one of the following:
* symptoms consistent with pulmonary disease
* chest X-rays consistent with lung disease
* pulmonary function tests consistent with lung disease
* lung biopsy consistent with lung disease
* family history of lung disease
* disease of organs with know associated with lung disease
* individuals suspected of history of lung disease based on history and/or physical examination
* normal controls (individuals without history of lung disease) to be sampled to provide a comparison to the lung disease cohort.
Exclusion Criteria
* Females who are pregnant or nursing
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Weill Medical College of Cornell University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Ronald G Crystal, MD
Role: PRINCIPAL_INVESTIGATOR
The New York Presbyterian Hospital -- Weill Medical College of Cornell University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
New York Presbyterian Hospital -- Weill Cornell Medical College of Cornell University
New York, New York, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
0508008095
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.